Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript

Abraxis BioScience, Inc. (ABII) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/29/2010 BW Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
07/23/2010 BW ABRAXANE® Approved for Marketing in Japan for Breast Cancer
07/19/2010 BW Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc.
07/12/2010 BW Faruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABII
07/07/2010 BW The Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABII
07/02/2010 BW Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition
06/30/2010 BW Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc.
06/30/2010 BW Robbins Umeda LLP Announces an Investigation of the Acquisition of Abraxis BioScience Inc. by Celgene Corporation
06/30/2010 BW Finkelstein Thompson LLP Announces Investigation of Abraxis Bioscience Inc.
06/30/2010 BW Ryan & Maniskas, LLP Announces Investigation of Abraxis BioScience, Inc.
06/30/2010 BW Kendall Law Group Investigates Abraxis BioScience Inc. Merger for Shareholders
06/30/2010 BW Rigrodsky & Long, P.A. Investigates Abraxis BioScience Inc. Buyout
06/30/2010 BW Bernstein Liebhard LLP Announces Investigation of Acquisition of Abraxis BioScience Inc. by Celgene Corp.
05/18/2010 BW Over 30 Scientific Presentations at ASCO Exploring ABRAXANE's Expanded Potential in Multiple Difficult-to-Treat Cancers
05/14/2010 BW Saint John??s Trustee & Abraxis Founder Patrick Soon-Shiong, M.D. Receives Distinguished Medical Science Award from the Friends of the National Library of Medicine
05/06/2010 BW Abraxis BioScience Reports First Quarter 2010 Financial Results
04/20/2010 BW ABRAXANE® in Combination with Bevacizumab Shows Promise in New Model of Triple Negative Breast Cancer
04/13/2010 BW Abraxis Founder & Executive Chairman to Present at 7th Annual World Health Care Congress
04/13/2010 BW Scottish Medicines Consortium Accepts ABRAXANE® for Use within National Health Service for Scotland
04/08/2010 BW Abraxis to Present Phase I/II Pancreatic Survival Data at 101st Annual Meeting of the American Association for Cancer Research
03/17/2010 BW ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
03/11/2010 BW Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results
03/03/2010 BW Sanjay Gupta, Abraxis Senior Vice President and Advisor to the Executive Chairman, Named Young Global Leader by the World Economic Forum
02/24/2010 BW Abraxis BioScience Announces Date for 2009 Fourth Quarter Financial Results and Investor Conference Call

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy